Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8TXX9

Entry ID Method Resolution Chain Position Source
AF-Q8TXX9-F1 Predicted AlphaFoldDB

No variants for Q8TXX9

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8TXX9

No associated diseases with Q8TXX9

3 regional properties for Q8TXX9

Type Name Position InterPro Accession
conserved_site Translationally controlled tumour protein, conserved site 45 - 55 IPR018103-1
conserved_site Translationally controlled tumour protein, conserved site 127 - 149 IPR018103-2
domain Translationally controlled tumour protein (TCTP) domain 1 - 172 IPR034737

Functions

Description
EC Number 3.5.2.3 In cyclic amides
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
dihydroorotase activity Catalysis of the reaction: (S)-dihydroorotate + H(2)O = N-carbamoyl-L-aspartate + H(+).
zinc ion binding Binding to a zinc ion (Zn).

1 GO annotations of biological process

Name Definition
'de novo' UMP biosynthetic process The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MLALRVLLKG KILIGGRVRE REVLAEDGWI VKIGKRLNEE ADLTLELGKR ELAVPAPIDL
70 80 90 100 110 120
HVHCRDPHPD YPFGFKTETR RFLLGGVATV VDMPNTRPAP TTPETYYEKE ELARENAEIE
130 140 150 160 170 180
VIVAGGVRDS QCTKELVEAG AYVLGEVFLA TSTDAPAVPW STLPEIFREL SPDGPLTIFH
190 200 210 220 230 240
PELDELVAER PARNLYEHLK NRPPEAETTA VGLLAGLKVR YPSRIHLSHV TLPESVKIAK
250 260 270 280 290 300
GADITVDVTP HHLFFDVLRV DPEDPVFKVN PPLRGRHHRL GLLRAVRRGD VDVLASDHAP
310 320 330 340 350 360
HILEDEFEDV PSGVTGGEII LPAALTLHRR FGLSLRDAVA MITCRPAKLL GRDDLGEVAV
370 380 390 400 410 420
GKRARITVVR MREFVVRAEE FGEEDRKFPY DGMRMFGEPV KLIDGTKVYD LKESRREGKP
VILEGE